Related references
Note: Only part of the references are listed.HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
Lung-Yi Mak et al.
HEPATOLOGY (2021)
Review of Lambda Interferons in Hepatitis B Virus Infection: Outcomes and Therapeutic Strategies
Laura A. Novotny et al.
VIRUSES-BASEL (2021)
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Nina Le Bert et al.
GASTROENTEROLOGY (2020)
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Carolina Boni et al.
GASTROENTEROLOGY (2019)
Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B
Shishu Zhu et al.
JOURNAL OF HEPATOLOGY (2019)
Soluble immune markers in the different phases of chronic hepatitis B virus infection
Steffen B. Wiegand et al.
SCIENTIFIC REPORTS (2019)
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection
Jordan J. Feld et al.
HEPATOLOGY (2019)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B
G. L. -H. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant
William S. Mason et al.
GASTROENTEROLOGY (2016)
Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype
Marc G. Ghany et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Children with Chronic Hepatitis B in the United States and Canada
Kathleen B. Schwarz et al.
JOURNAL OF PEDIATRICS (2015)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B
Shi-Wu Ma et al.
JOURNAL OF HEPATOLOGY (2012)
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa
Shaoyang Wang et al.
VIROLOGY JOURNAL (2011)
Association of Interleukin-18 Gene Polymorphisms with Hepatitis B Virus Clearance
Jae Youn Cheong et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Serum Levels of Interleukin-10 and Interleukin-12 Predict Early, Spontaneous Hepatitis B Virus e Antigen Seroconversion
Jia-Feng Wu et al.
GASTROENTEROLOGY (2010)
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B
Anthony T. Tan et al.
JOURNAL OF HEPATOLOGY (2010)
Modulation of Serum Interleukin-18 Concentrations and Hepatitis B Virus DNA Levels During Interferon Therapy in Patients with Hepatitis B e-Antigen-Positive Chronic Hepatitis B
Staffan P. E. Sylvan et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Interferon treatment for chronic hepatitis B: Enhanced response in children 5 years old or younger
GE Kobak et al.
JOURNAL OF PEDIATRICS (2004)